MntC recombinant protein of staphylococcus aureus and preparation method and application thereof

A technology of recombinant protein and Staphylococcus, which is applied in the biological field, can solve the problems of toxicity and achieve the effects of high expression, strong immunogenicity, and easy separation and purification

Active Publication Date: 2014-04-02
CHENGDU OLYMVAX BIOPHARM +1
View PDF3 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, excessive intake of this element can lead to t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MntC recombinant protein of staphylococcus aureus and preparation method and application thereof
  • MntC recombinant protein of staphylococcus aureus and preparation method and application thereof
  • MntC recombinant protein of staphylococcus aureus and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] Example 1: Codon optimization of encoding MntC and construction of expression vector and expression engineering bacteria

[0096] According to the coding preference of Escherichia coli, the coding of the gene SAR0641 encoding MntC in the MRSA-252 genome (GI: 49240382) was optimized as follows:

[0097] The 9th codon (encoding Leu) of the wild-type MntC protein coding sequence (SEQ ID NO.5) was optimized as CTG, the 13th and 14th codons (encoding Thr) were optimized as ACC, and the 27th, 65th, and 282nd codons The codon (encoding Gly) was optimized to GGT, the 214th codon (encoding Arg) was optimized to CGT, and the optimized nucleotide sequence (SEQ ID NO.2) was obtained. The amino acid sequence encoded by this sequence is shown in SEQ ID NO. The 6th to 290th bits of 1 are displayed.

[0098] The optimized sequence was handed over to Shanghai Jierui Biotechnology Co., Ltd. for whole gene synthesis, and BamHI and NotI were used as the end-to-end restriction sites to lig...

Embodiment 2

[0099] Embodiment 2: the construction of wild MntC expression vector and expression bacteria

[0100] 1. Take the MRSA-252 strain and spread it on MH agar plate (Mueller-Hinton Agar, Beijing Aoboxing Biotechnology Co., Ltd., LOT: 02-051) for recovery, and cultivate it aerobically at 37°C overnight. Pick a single colony and inoculate 1000ml of MH (Mueller-Hinton, Beijing Aoboxing Biotechnology Co., Ltd., LOT: 02-052) liquid medium, culture at 37°C with aerobic shaking at 210rpm for 7h, and extract the MRSA genome.

[0101] 2. Use the genome extracted in step 1 as a template to amplify the MntC target gene fragment. The amplification steps are as follows:

[0102] 1) Design the PCR primers as follows, respectively (the base sequence of the restriction site is underlined)

[0103] Forward primer: PMNTCBAMHI1 (SEQ ID NO.3:

[0104] 5'-CTG GGATCC AGCAGTGATAAGTCAAATGCAAAC-3';

[0105] BamHI

[0106] Reverse primer: PMNTCNOTI2 (SEQ ID NO.4):

[0107] 5'-AT GCGGCCGC CTTATTATT...

Embodiment 3

[0135] Example 3: Induced expression of MntC in prokaryotic expression system-Escherichia coli

[0136] 1. Induced expression of target protein

[0137] 1) Take 100 μL of the correctly identified pGEX-6P-2-MntC(wt) / XL1-blue bacterial solution and the whole gene synthetic pGEX-6P-2-MntC(r) / XL1-blue bacterial solution and add to 10mL containing 100μg / In the LB medium of ml Amp, cultivate overnight at 80rpm at 37°C, take 2mL of the overnight cultured bacterial solution and add them to 100mL LB medium containing 100μg / ml Amp; when the OD600 is 0.8-1.0, add IPTG to make the final concentration 200 μM, then placed on a shaking table to induce expression at 30°C for 3h, and then induced expression at 16°C overnight.

[0138] 2) Take out the bacterial solution after induced expression, centrifuge at 10000rpm for 5min, discard the supernatant, add 5mL of lysis buffer (PBS) to mix, and lyse with ultrasonic (power 300 watts) for 10min (work for 6 seconds, rest for 9 seconds), and then ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biotechnology, and relates to a MntC recombinant protein of staphylococcus aureus (SA), a carrier comprising the recombinant protein, a host, a composition or a kit, application, preparation, fermentation and purification method of the protein. The MntC recombinant protein prepared by the method has strong immunogenicity, is safe and non-toxic, and is proved by animal tests to be able to effectively stimulate an organism to generate high efficient humoral immune response and good immune protection.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a MntC recombinant protein of Staphylococcus aureus (SA). Background technique [0002] Staphylococcus aureus (Staphylococcus aureus, SA), hereinafter referred to as Staphylococcus aureus, has another name of "flesh-loving bacteria". As a representative of Gram-positive bacteria, it is an important pathogenic bacteria causing nosocomial infection and community infection. Infection is characterized by acute and purulent, and local infection can cause purulent infection of skin and soft tissue, etc., which will not heal after a long time; systemic infection can lead to osteomyelitis, septic arthritis, endocarditis, pneumonia, sepsis, etc. Severe infection and complications, the mortality rate is as high as 20%. At the same time, the exotoxin of Staphylococcus aureus can also cause systemic fatal infections such as food poisoning, scalded skin syndrome and toxic shock syndrome. Therefo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/31C12N15/31C12N15/74C12N1/21C12P21/02C07K1/22C07K1/18A61K39/085A61P31/04C07K16/12G01N33/68G01N33/569C12R1/445
CPCA61K39/00A61K2039/505C07K14/31C07K16/1271G01N2333/31
Inventor 曾浩邹全明樊绍文卢陆杨茜敬海明
Owner CHENGDU OLYMVAX BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products